These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31921121)

  • 1. The Co-inhibitor BTLA Is Functional in ANCA-Associated Vasculitis and Suppresses Th17 Cells.
    Werner K; Dolff S; Dai Y; Ma X; Brinkhoff A; Korth J; Gäckler A; Rohn H; Sun M; Cohen Tervaert JW; van Paassen P; Kribben A; Witzke O; Wilde B
    Front Immunol; 2019; 10():2843. PubMed ID: 31921121
    [No Abstract]   [Full Text] [Related]  

  • 2. Decreased B and T lymphocyte attenuator in Behcet's disease may trigger abnormal Th17 and Th1 immune responses.
    Ye Z; Deng B; Wang C; Zhang D; Kijlstra A; Yang P
    Sci Rep; 2016 Feb; 6():20401. PubMed ID: 26841832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial DNA motifs trigger ANCA production in ANCA-associated vasculitis in remission.
    Tadema H; Abdulahad WH; Lepse N; Stegeman CA; Kallenberg CG; Heeringa P
    Rheumatology (Oxford); 2011 Apr; 50(4):689-96. PubMed ID: 21149241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced activated regulatory T cells and imbalance of Th17/activated Treg cells marks renal involvement in ANCA-associated vasculitis.
    Wang Y; Zhang S; Zhang N; Feng M; Liang Z; Zhao X; Gao C; Qin Y; Wu Y; Liu G; Zhao J; Guo H; Luo J
    Mol Immunol; 2020 Feb; 118():19-29. PubMed ID: 31837507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BTLA Expression on Th1, Th2 and Th17 Effector T-Cells of Patients with Systemic Lupus Erythematosus Is Associated with Active Disease.
    Oster C; Wilde B; Specker C; Sun M; Kribben A; Witzke O; Dolff S
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31514450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Frequencies of Switched Memory B Cells and Plasmablasts in Peripheral Blood from Patients with ANCA-Associated Vasculitis.
    Elmér E; Smargianaki S; Pettersson Å; Skattum L; Ohlsson S; Hellmark T; Johansson ÅCM
    J Immunol Res; 2020; 2020():8209737. PubMed ID: 33313327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting immune checkpoints in anti-neutrophil cytoplasmic antibodies associated vasculitis: the potential therapeutic targets in the future.
    Pan M; Zhao H; Jin R; Leung PSC; Shuai Z
    Front Immunol; 2023; 14():1156212. PubMed ID: 37090741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic Characterization of Circulating CD4
    Lilliebladh S; Johansson Å; Pettersson Å; Ohlsson S; Hellmark T
    J Immunol Res; 2018; 2018():6984563. PubMed ID: 30510966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of high mobility group box 1 on Toll-like receptor 9 in B cells in myeloperoxidase-ANCA-associated vasculitis.
    Wang C; Deng H; Gong Y; You R; Chen M; Zhao MH
    Autoimmunity; 2020 Feb; 53(1):28-34. PubMed ID: 31790283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High BTLA Expression Likely Contributes to Contraction of the Regulatory T Cell Subset in Lupus Disease.
    Aubergeon L; Sawaf M; Felten R; Gottenberg JE; Dumortier H; Monneaux F
    Front Immunol; 2021; 12():767099. PubMed ID: 34899718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered B cell balance, but unaffected B cell capacity to limit monocyte activation in anti-neutrophil cytoplasmic antibody-associated vasculitis in remission.
    Lepse N; Abdulahad WH; Rutgers A; Kallenberg CG; Stegeman CA; Heeringa P
    Rheumatology (Oxford); 2014 Sep; 53(9):1683-92. PubMed ID: 24729403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients.
    Karabon L; Partyka A; Ciszak L; Pawlak-Adamska E; Tomkiewicz A; Bojarska-Junak A; Roliński J; Wołowiec D; Wrobel T; Frydecka I; Kosmaczewska A
    J Immunol Res; 2020; 2020():6545921. PubMed ID: 32775467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal expression pattern of the IL-2 receptor β-chain on CD4+ T cells in ANCA-associated vasculitis.
    Wilde B; Hoerning A; Kribben A; Witzke O; Dolff S
    Dis Markers; 2014; 2014():249846. PubMed ID: 24648606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and clinical significance of B and T lymphocyte attenuator on CD4
    Shen X; Zhang J; Tang P; Song H; Liu X; Huang Z; Zhang X; Wang X; Wu M
    Indian J Pathol Microbiol; 2019; 62(2):232-238. PubMed ID: 30971546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring Frequencies of Circulating Specific Th17 Cells against Myeloperoxidase and Proteinase 3 in ANCA Associated Vasculitis.
    Martinez Valenzuela L; Draibe J; Quero M; Fulladosa X; Cruzado JM; Bestard O; Torras J
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31756913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with antineutrophil cytoplasmic antibody-associated vasculitis have defective Treg cell function exacerbated by the presence of a suppression-resistant effector cell population.
    Free ME; Bunch DO; McGregor JA; Jones BE; Berg EA; Hogan SL; Hu Y; Preston GA; Jennette JC; Falk RJ; Su MA
    Arthritis Rheum; 2013 Jul; 65(7):1922-33. PubMed ID: 23553415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of CD4 T cell subpopulations in ANCA-associated vasculitis.
    Marinaki S; Neumann I; Kälsch AI; Grimminger P; Breedijk A; Birck R; Schmitt W; Waldherr R; Yard BA; Van Der Woude FJ
    Clin Exp Immunol; 2005 Apr; 140(1):181-91. PubMed ID: 15762890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased numbers of blood dendritic cells and defective function of regulatory T cells in antineutrophil cytoplasmic antibody-associated vasculitis.
    Rimbert M; Hamidou M; Braudeau C; Puéchal X; Teixeira L; Caillon H; Néel A; Audrain M; Guillevin L; Josien R
    PLoS One; 2011 Apr; 6(4):e18734. PubMed ID: 21494636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are urinary levels of high mobility group box 1 markers of active nephritis in anti-neutrophil cytoplasmic antibody-associated vasculitis?
    de Souza AW; Abdulahad WH; Sosicka P; Bijzet J; Limburg PC; Stegeman CA; Bijl M; Westra J; Kallenberg CG
    Clin Exp Immunol; 2014 Nov; 178(2):270-8. PubMed ID: 25052363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B and T Lymphocyte Attenuator is a Target of miR-155 during Naïve CD4+ T Cell Activation.
    Liu Y; Nie W; Jin Y; Zhuo A; Zang Y; Xiu Q
    Iran J Immunol; 2016 Jun; 13(2):89-99. PubMed ID: 27350630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.